Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» March 2012
March 2012
Repligen Announces FDA Advisory Committee Date for SecreFlo™ NDA
Repligen Announces FDA Advisory Committee Date for SecreFlo™ NDA
Yahoo/BusinessWire
Repligen
SecreFlo
pancreatitis
Positive FDA Recommendation For Drug Good New For Tekmira
Positive FDA Recommendation For Drug Good New For Tekmira
Seeking Alpha
FDA
Tekmira Pharmaceuticals
Talon Therapeutics
Marqibo
Clovis Oncology plans $75 million stock offering
Clovis Oncology plans $75 million stock offering
Yahoo/AP
Clovis Oncology
stock offering
Addex surges on upbeat data from Parkinson's drug trial
Addex surges on upbeat data from Parkinson's drug trial
Fierce Biotech
Addex
Parkinson's Disease
dipraglurant
Durata, with license to Pfizer drug, lays plans for $86M IPO
Durata, with license to Pfizer drug, lays plans for $86M IPO
Fierce Biotech
Durata
Pfizer
IPOs
dalbavancin
Sanofi: A Good Long-Term Dividend Play?
Sanofi: A Good Long-Term Dividend Play?
Seeking Alpha
Sanofi
dividends
Merck
Pfizer
GSK lung drug has mixed results but filing on track
GSK lung drug has mixed results but filing on track
Reuters
GSK
Relovair
COPD
Theravance
4 Biopharma Swing Trades For The Mid Term - 3 Week Report Card
4 Biopharma Swing Trades For The Mid Term - 3 Week Report Card
Seeking Alpha
Ariad Pharmaceuticals
Sanofi
Spectrum Pharmaceuticals
Questcor
Antares
Why ViroPharma May Be About to Take Off
Why ViroPharma May Be About to Take Off
Motley Fool
ViroPharma
Obesity Drug Candidates' Parallels With Approval Process Of Other Drugs
Obesity Drug Candidates' Parallels With Approval Process Of Other Drugs
Seeking Alpha
obesity
Orexigen
Arena
Avanir
Dendreon
FDA
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »